Symbol | Exchange | Currency |
|---|
Investing.com - Clene (NASDAQ: CLNN) reported first quarter EPS of $-0.15, worse than the analyst estimate of $-0.14. Revenue for the quarter came in at $100K versus the consensus...
Investing.com - Clene (NASDAQ: CLNN) reported first quarter EPS of $-0.01, $0.11 better than the analyst estimate of $-0.12. Revenue for the quarter came in at $234.0K versus the...
Clene Inc. is a clinical-stage biopharmaceutical company. The Company is focused on treatment of neurodegenerative disease by targeting energetic failure, an underlying cause of many neurological diseases. Its drug candidate, CNM-Au8, is an oral suspension of gold nanocrystals developed to restore neuronal health and function by increasing energy production and utilization. The catalytically active nanocrystals of CNM-Au8 drive critical cellular energy producing reactions that enable neuroprotection and remyelination by increasing neuronal and glial resilience to disease-relevant stressors. Its other products include CNM-ZnAg and CNM-AgZn17. CNM-ZnAg is a spectrum antiviral, antibacterial agent comprised of zinc and silver ions under development to treat infectious disease and to provide immune support for symptom resolution. CNM-AgZn17 is a gel polymer suspension of zinc and silver under development for treatment of infectious diseases and to support wound healing.
| Average | 8.43 (+702.72% Upside) |
| High | 15.00 |
| Low | 4.00 |
| Price | 1.05 |
| No. of Analysts | 7 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Buy | Strong Sell |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2.88 | 2.90 | 2.60 | +0.29 | +11.20% | 316.80K | NASDAQ | |||
| 397.70 | 400.50 | 383.40 | +19.36 | +5.12% | 62.31M | NASDAQ | |||
| 74.61 | 75.11 | 73.28 | 0.00 | 0.00% | 1.90M | NYSE | |||
| 0.984 | 1.00 | 0.95 | +0.054 | +5.80% | 54.13K | OTC Markets | |||
| 34.40 | 34.85 | 34.10 | 0.00 | 0.00% | 0.00 | NYSE | |||
| 57.44 | 58.16 | 56.98 | -0.54 | -0.93% | 2.87M | NYSE | |||
| 3.36 | 3.45 | 3.16 | +0.190 | +5.99% | 1.21M | NYSE | |||
| 27.40 | 27.51 | 27.00 | +0.66 | +2.48% | 60.30K | OTC Markets | |||
| 0.0002 | 0.0002 | 0.0001 | +0.00020 | +1,000.00% | 1.97M | OTC Markets | |||
| 0.555 | 0.56 | 0.531 | +0.030 | +5.71% | 84.81K | NASDAQ | |||
| 53.63 | 53.63 | 52.66 | 0.00 | 0.00% | 0.00 | NYSE | |||
| 12.98 | 13.02 | 12.98 | +0.12 | +0.97% | 255.00 | NASDAQ | |||
| 9.74 | 9.75 | 9.73 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 0.017 | 0.017 | 0.015 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 12.54 | 13.02 | 12.39 | -0.13 | -1.03% | 538.95K | NASDAQ |